Filing Details

Accession Number:
0000874716-24-000109
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-20 17:00:34
Reporting Period:
2024-05-17
Accepted Time:
2024-05-20 17:00:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403694 L. Bruce Claflin One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-17 200 $540.80 161 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,560 Indirect by Claflin Family Trust
Footnotes
  1. Shares of Issuer common stock held by the Claflin Family Trust ('Trust') of which the reporting person's spouse is the trustee for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of the shares held in the Trust and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.